Autism

Recent articles

Research image of neurons with variants of the KCNQ2 gene (bottom row) developing more synaptic protein groups (pink and blue) than control neurons (top row).

ADSI, leucovorin, autism registry; and more

Here is a roundup of autism-related news and research spotted around the web for the week of 6 October.

By Jill Adams
7 October 2025 | 2 min read
Composite of Autism Data Science Initiative researcher headshots.

Meet the Autism Data Science Initiative grantees

The awarded projects plan to study gene-and-environment interactions in people, stem cells and organoids, as well as predictors of positive life outcomes in autistic youth and adults.

By Calli McMurray
3 October 2025 | 2 min read
Stack of papers.

Exclusive: The 23 studies the FDA based its expanded leucovorin label on

The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.

By Claudia López Lloreda
2 October 2025 | 6 min read
Hand holding a rubber stamp above a stack of papers.

Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns

An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.

By Calli McMurray
2 October 2025 | 10 min read
Richard Frye.

Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?

Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.

By Brendan Borrell
1 October 2025 | 11 min read
Portrait photograph of Dame Stephanie Shirley.

In memoriam: Stephanie “Steve” Shirley, autism philanthropist

Fueled by business success and her son, she played an outsized role in British autism research.

By Lauren Schneider
25 September 2025 | 6 min read
Research image of oxytocin receptors in rats.

Impaired sensory learning in a mouse model of fragile X syndrome; and more

Here is a roundup of autism-related news and research spotted around the web for the week of 22 September.

By Jill Adams
23 September 2025 | 2 min read
A blue shape emanates from a megaphone.

Autism experts question HHS statements on Tylenol, leucovorin

Concerns include the administration’s reliance on weak, correlational evidence rather than established research.

By The Transmitter
22 September 2025 | 9 min listen
Research image visualizing genetic variation.

Long-read sequencing unearths overlooked autism-linked variants

Strips that are thousands of base pairs in length offer better resolution of structural variants and tandem repeats, according to two independent preprints.

By Natalia Mesa
18 September 2025 | 6 min read
Research image of different types of microglia in mice.

Autism and anxiety insights; and more

Here is a roundup of autism-related news and research spotted around the web for the week of 15 September.

By Jill Adams
16 September 2025 | 2 min read

Explore more from The Transmitter

A drosophila connectome.

One year of FlyWire: How the resource is redefining Drosophila research

We asked nine neuroscientists how they are using FlyWire data in their labs, how the connectome has transformed the field and what new tools they would like to see in the future.

By Francisco J. Rivera Rosario
7 October 2025 | 3 min read
Research image of axons forming a path into brain metastases of small-cell lung cancer, integrating tumors into the brain.

Neurons fuel lung tumors that have spread to brain

Functional synapses between brain cells and cancer cells are key to the metastatic growth, according to new findings from two independent teams.

By Sarah DeWeerdt
6 October 2025 | 7 min listen
Illustration of a brain surrounded by a stylized silhouette of a human head with psychedelic colors and textures.

Why we need basic science to better understand the neurobiology of psychedelics

Despite the many psychedelics clinical trials underway, there is still much we don’t know about how these drugs work. Preclinical studies represent our best viable avenue to answer these lingering questions.

By Devin Effinger, Melissa Herman
1 October 2025 | 7 min listen

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.